HIGHLIGHTS
- who: Yue Han et al. from the Department of Clinical Laboratory, The Secondary Hospital of Tianjin Medical University, Tianjin, China have published the research: KIF11 Is a Promising Therapeutic Target for Thyroid Cancer Treatment, in the Journal: Computational and Mathematical Methods in Medicine of 16/08/2022
- what: This study was aimed at investigating the expression of KIF11 in thyroid cancer tissues and clarifying its effects on the progression of thyroid cancer. The study investigated another member of the KIF family, KIF11, affecting the proliferation and apoptosis of thyroid cancer cells.
- how: The . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.